🔎 Trials Near Me

Gara Jalqabaatti › Sukkaraa Gosa 2 › Texas › Dallas

Qorannoo klinikaalii Sukkaraa Gosa 2 Dallas, TX keessatti

Qorannoo 19 Sukkaraa Gosa 2 f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Namoota walitti qabaa jiraSadarkaa 3
  • North Texas Endocrine Center, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Soltero Cardiovascular Research Center, Dallas
  • North Texas Endocrine Center, Dallas
  • Southwest Family Medicine Associates, Dallas
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Namoota walitti qabaa jiraSadarkaa 3
  • University of Texas Southwestern Medical Center, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07754461

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Namoota walitti qabaa jira
  • University of Texas Southwestern Medical Center, Dallas
  • Parkland Health & Hospital System (PHHS), Dallas
  • Baylor Scott and White - Health System, Dallas
Umuriin hundi · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06593327

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Velocity Clinical Research, Dallas, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Namoota walitti qabaa jiraSadarkaa 2
  • M3 Wake Research - Dallas, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Velocity Clinical Research, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 2
  • University of Texas Southwestern Medical Center, Dallas
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Namoota walitti qabaa jiraSadarkaa 2
  • M3 Wake Research Dallas - Internal Medicine, Dallas
  • Revival Research Institute, LLC, Dallas
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Namoota walitti qabaa jiraSadarkaa 2
  • Velocity Clinical Research - Dallas, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07215559

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Namoota walitti qabaa jiraSadarkaa 3
  • Thyroid Endocrinology & Diabetes PA, Dallas
  • Baylor Jack and Jane Hamilton, Dallas
Umuriin 45 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07662109

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Namoota walitti qabaa jiraSadarkaa 3
  • Research Institute of Dallas, Dallas
Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06739122

Polypill for Prevention of Cardiomyopathy

Namoota walitti qabaa jiraSadarkaa 1/2
  • UT Southwestern Medical Center, Dallas
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06143566

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Namoota walitti qabaa jiraSadarkaa 2
  • Zenos Clinical Research, Dallas
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 15-Wax-2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 2
  • Velocity Clinical Research Dallas, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Elb-2026 · NCT07546929

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Namoota walitti qabaa jira
  • UT Southwestern Medical Center, Dallas
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 10-Gur-2026 · NCT05168605

Qorannoo Sukkaraa Gosa 2 magaalota biroo keessatti

Qorannoo biroo Dallas keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.